UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Notis McConarty Edward

Notis McConarty Edward trimmed its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 3.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 7,823 shares of the healthcare conglomerate’s stock after selling 239 shares during the period. UnitedHealth Group makes up about 1.9% of Notis McConarty Edward’s portfolio, making the stock its 19th biggest position. Notis McConarty Edward’s holdings in UnitedHealth Group were worth $3,957,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in UNH. Riverwater Partners LLC raised its stake in shares of UnitedHealth Group by 6.3% during the 4th quarter. Riverwater Partners LLC now owns 2,531 shares of the healthcare conglomerate’s stock valued at $1,280,000 after buying an additional 151 shares during the last quarter. Somerville Kurt F lifted its holdings in UnitedHealth Group by 0.5% in the fourth quarter. Somerville Kurt F now owns 25,368 shares of the healthcare conglomerate’s stock valued at $12,833,000 after acquiring an additional 118 shares during the period. Smith Moore & CO. grew its stake in shares of UnitedHealth Group by 2.9% during the 4th quarter. Smith Moore & CO. now owns 2,161 shares of the healthcare conglomerate’s stock worth $1,093,000 after purchasing an additional 60 shares during the period. Broderick Brian C lifted its stake in shares of UnitedHealth Group by 5.9% in the 4th quarter. Broderick Brian C now owns 22,761 shares of the healthcare conglomerate’s stock valued at $11,514,000 after purchasing an additional 1,264 shares during the period. Finally, George Kaiser Family Foundation acquired a new stake in UnitedHealth Group during the fourth quarter valued at $236,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

Wall Street Analyst Weigh In

UNH has been the topic of a number of analyst reports. KeyCorp restated an “overweight” rating and set a $650.00 target price on shares of UnitedHealth Group in a research report on Friday, January 17th. Piper Sandler reduced their target price on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a research note on Thursday, January 2nd. Cantor Fitzgerald reissued an “overweight” rating and issued a $700.00 price target on shares of UnitedHealth Group in a report on Friday, January 17th. Wells Fargo & Company dropped their target price on shares of UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating on the stock in a research report on Tuesday, January 28th. Finally, Barclays lowered their price objective on UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating on the stock in a report on Friday, January 17th. Twenty investment analysts have rated the stock with a buy rating and two have given a strong buy rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Buy” and an average price target of $629.32.

Insider Transactions at UnitedHealth Group

In other news, Director Timothy Patrick Flynn bought 1,000 shares of the company’s stock in a transaction on Friday, January 17th. The stock was bought at an average cost of $511.57 per share, with a total value of $511,570.00. Following the transaction, the director now directly owns 4,500 shares in the company, valued at $2,302,065. The trade was a 28.57 % increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Company insiders own 0.33% of the company’s stock.

UnitedHealth Group Stock Performance

UnitedHealth Group stock opened at $524.94 on Friday. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $630.73. The stock has a market cap of $480.17 billion, a price-to-earnings ratio of 33.87, a price-to-earnings-growth ratio of 1.37 and a beta of 0.62. The firm has a 50 day simple moving average of $509.24 and a 200-day simple moving average of $542.37. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business had revenue of $100.81 billion during the quarter, compared to analysts’ expectations of $101.60 billion. During the same period in the prior year, the business posted $5.83 EPS. The company’s revenue was up 6.8% compared to the same quarter last year. On average, analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were paid a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a yield of 1.60%. The ex-dividend date was Monday, March 10th. UnitedHealth Group’s dividend payout ratio (DPR) is 54.19%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.